Appeal No. 2003-1489 Application No. 09/256,486 "[t]here is no disclosure or suggestion that imaging is performed within Gavin regardless of the type of light source."5 Appellant also maintains that there is no disclosure in Gavin regarding the known spatial location of the "feature" (clot-promoting agent 28). However, appellant acknowledges that Gavin discloses that agent 28 is located between the restricted areas 42 and the drive apertures 35 of the conduits, and such disclosure meets the claimed requirement of a feature located within the chamber at a known spatial location. Also, inasmuch as appellant's specification defines "feature" as including physical and geometric characteristics of the chamber, Gavin's disclosure of restricted area 42 meets the claimed requirement for such feature. We are also not persuaded by appellant's argument that "[n]either Gavin nor Van Deusen disclose [sic, discloses] or suggest [sic, suggests] a container having a chamber for quiescently holding a biologic sample, wherein the sample can be imaged within the chamber."6 Again, appellant has not refuted the examiner's reasonable finding that the chambers of Gavin are fully capable of quiescently holding a sample which can be 5 Page 12 of principal brief, last sentence. 6 Page 14 of principal brief, first paragraph. -6-Page: Previous 1 2 3 4 5 6 7 8 9 10 11 NextLast modified: November 3, 2007